Related Experiment Video
Updated: Jun 1, 2026
11:19
Robotic Myotomy and Partial Fundoplication for Achalasia
Published on: August 11, 2023
[Gastrointestinal tract polyps in acromegaly patients]
Anna Krzentowska1, Filip Gołkowski, Agata Bałdys-Waligórska
1Katedra i Klinika Endokrynologii, Uniwersytet Jagielloński, Collegium Medicum, Kraków. akrzentowska@su.krakow.pl
Przeglad Lekarski
|May 20, 2011
Summary
The duration of uncontrolled acromegaly, not hormone levels at diagnosis, significantly increases the risk of developing colon polyps. Regular colonoscopies are recommended for acromegaly patients.
Area of Science:
- Endocrinology
- Gastroenterology
- Oncology
Context:
- Acromegaly, a rare chronic disease caused by excess growth hormone (GH), is linked to serious complications, including malignancies.
- Colon polyps are frequently observed in acromegaly patients, second only to thyroid nodules.
Purpose:
- To determine the prevalence of colon polyps in patients diagnosed with acromegaly.
- To investigate the correlation between colon polyp development and factors such as disease duration and hormonal levels at diagnosis.
Summary:
- A study of 31 acromegaly patients revealed a 41.9% prevalence of colon polyps.
- Colon polyp occurrence was significantly associated with the duration of uncontrolled acromegaly (median 10 years vs. 6.5 years).
- Hormone levels (IGF-1, GH) at diagnosis did not correlate with polyp prevalence.
Impact:
- Findings emphasize that prolonged, uncontrolled acromegaly is a key risk factor for colon polyp development.
- The study supports routine colonoscopy screening for individuals with acromegaly.
- Highlights the importance of managing disease duration to mitigate cancer risks.
Related Concept Videos
01:20Gastrointestinal Motility Disorders
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
01:11Pyloric Obstruction
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
01:27Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...